Barclays reduced its price target on Reinsurance Group of America, Incorporated to $237 from $251 on January 8. The firm kept an Overweight rating on the stock.
The adjustment came as part of Barclays' broader outlook refresh for 2026. Analysts said they are feeling "cautiously optimistic" about the life insurance sector heading into that year.
Barclays noted the group's strong capital levels, steady cash generation, and ongoing consolidation activity. The firm believes these factors can help offset pressure from spread compression and higher technology-related spending.
In October, Reinsurance Group of America announced a strategic investment in FoxPath Capital Partners. The New York-based firm specializes in credit secondaries.
RGA also made a multi-fund anchor commitment to FoxPath Capital Partners. The company stated the move provides greater access to high-quality private assets in the expanding credit secondary market.
Company officials said the investment improves portfolio flexibility and creates additional long-term investment opportunities. Reinsurance Group of America is a global leader in life and health reinsurance.
The company offers solutions that help clients manage risk and optimize capital. Reinsurance Group of America is included among 14 Best Mid Cap Dividend Aristocrat Stocks to Buy Now.